Skip to contentB
BioCorRx Inc.
B
BICXBioCorRx Inc. Q3 2017 · 10-Q
Revenue$147.59K$147.59K−11.9% vs Q3 2016 Net Income-$1.10M-$1.10MN/M vs Q3 2016 EPS Diluted$0.00$0.00N/M vs Q3 2016 Operating Income-$663,645N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
derived
Margins · derivedOperating margin-449.6%−140.9 pt vs Q3 2016
Net margin-746.7%+809.9 pt vs Q3 2016
ended Sep 30, 2017 · filed Nov 14, 2017 · 45 d after period end